Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

86.93EUR
3:50pm IST
Change (% chg)

€0.93 (+1.08%)
Prev Close
€86.00
Open
€86.40
Day's High
€87.38
Day's Low
€86.19
Volume
1,108,157
Avg. Vol
3,328,033
52-wk High
€101.10
52-wk Low
€69.58

SASY.PA

Chart for SASY.PA

About

Sanofi is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company is organized around three principal activities: Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. The Company invests in emerging markets,... (more)

Overall

Beta: 0.76
Market Cap(Mil.): €112,852.00
Shares Outstanding(Mil.): 1,312.23
Dividend: 2.85
Yield (%): 3.31

Financials

  SASY.PA Industry Sector
P/E (TTM): 23.62 35.92 36.12
EPS (TTM): 3.64 -- --
ROI: 6.46 15.30 14.76
ROE: 8.97 15.87 15.63
Search Stocks

Sanofi, Regeneron say new cholesterol drug data positive

PARIS - Sanofi and Regeneron Pharmaceuticals said on Tuesday that a study into their new cholesterol-lowering drug, Praluent, showed promising results.

01 Sep 2015

Sanofi, Regeneron say new cholesterol drug data positive

PARIS, Sept 1 - Sanofi and Regeneron Pharmaceuticals said on Tuesday that a study into their new cholesterol-lowering drug, Praluent, showed promising results.

01 Sep 2015

Google, Sanofi team up to improve diabetes care

- Google Inc and French drugmaker Sanofi SA said they will partner to develop tools to improve the management and treatment of diabetes.

01 Sep 2015

Google, Sanofi team up to improve diabetes care

REUTERS - Google Inc and French drugmaker Sanofi SA said they will partner to develop tools to improve the management and treatment of diabetes.

31 Aug 2015

Google, Sanofi team up to improve diabetes care

Aug 31 - Google Inc and French drugmaker Sanofi SA said they will partner to develop tools to improve the management and treatment of diabetes.

31 Aug 2015

French and Benelux stocks-Factors to watch on Tuesday

PARIS, Aug 11 - Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

11 Aug 2015

BRIEF-Evotec, Apeiron, Sanofi develop cancer immunotherapies

* Evotec, Apeiron Biologics and Sanofi jointly develop novel small molecule-based cancer immunotherapies Source text for Eikon: Further company coverage: (Reporting By Georgina Prodhan)

10 Aug 2015

Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills

PARIS - Sanofi is teaming up with Germany's Evotec and Austrian biotech firm Apeiron Biologics to develop a new type of immune system-boosting cancer medicine that could be given as tablets to fight both solid tumors and blood cancers.

10 Aug 2015

Sanofi teams up with Evotec, Apeiron to develop immuno-oncology pills

PARIS, Aug 10 - Sanofi is teaming up with Germany's Evotec and Austrian biotech firm Apeiron Biologics to develop a new type of immune system-boosting cancer medicine that could be given as tablets to fight both solid tumours and blood cancers.

10 Aug 2015

Sanofi links with Evotec to tap stem cells for diabetes care

- French drugmaker Sanofi is linking with Evotec to develop stem cell-based treatments for diabetes, under a deal that could earn the German biotech firm more than 300 million euros ($327 million).

07 Aug 2015

Earnings vs. Estimates

Search Stocks